tiprankstipranks
PreveCeutical Medical (PRVCF)
:PRVCF

PreveCeutical Medical (PRVCF) Price & Analysis

Compare
38 Followers

PRVCF Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

19.28%80.72%
19.28% Insiders
― Other Institutional Investors
80.72% Public Companies and
Individual Investors

PRVCF FAQ

What was PreveCeutical Medical ’s price range in the past 12 months?
PreveCeutical Medical lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
    What is PreveCeutical Medical ’s market cap?
    PreveCeutical Medical ’s market cap is $11.46M.
      When is PreveCeutical Medical ’s upcoming earnings report date?
      PreveCeutical Medical ’s upcoming earnings report date is Apr 30, 2025 which is in 67 days.
        How were PreveCeutical Medical ’s earnings last quarter?
        PreveCeutical Medical released its earnings results on Nov 21, 2024. The company reported >-$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-$0.001.
          Is PreveCeutical Medical overvalued?
          According to Wall Street analysts PreveCeutical Medical ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does PreveCeutical Medical pay dividends?
            PreveCeutical Medical does not currently pay dividends.
            What is PreveCeutical Medical ’s EPS estimate?
            PreveCeutical Medical ’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does PreveCeutical Medical have?
            PreveCeutical Medical has 541,703,370 shares outstanding.
              What happened to PreveCeutical Medical ’s price movement after its last earnings report?
              PreveCeutical Medical reported an EPS of >-$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of PreveCeutical Medical ?
                Currently, no hedge funds are holding shares in PRVCF
                ---

                Company Description

                PreveCeutical Medical

                PreveCeutical Medical, Inc. engages in licensing, branding and marketing of nutraceutical and wellness products. Its product include cellb9 immune system booster, which is an oral solution. PreveCeutical Medical was founded by Stephen Van Deventer, Kimberly Van Deventer, Greg Reid, Shabira Rajan, Mak Jawadekar, Harry Parekh, Nicole Goncalves-Krysinski, Lish Rebman and Sydney Cole on December 15, 2014 and is headquartered in Vancouver, Canada.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Tetra Bio-Pharma
                Curaleaf Holdings
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis